Since its inception in the 1970s, long-term intravenous (IV) antibiotic or antifungal therapy has become the standard approach for managing various infection types in patients. In specific cases, physicians prescribe home infusion of IV antibiotics or antifungals for patients who are well enough to receive treatment at home but require this method due to inadequate response to oral medications. It is crucial to have appropriate IV access for such treatments. Home-based IV antibiotics are typically reserved for a limited number of bacterial infections, as many mild to moderate infections can be effectively addressed with oral antibiotics. Unfortunately, due to the rising prevalence of antibiotic resistance in both hospital and community settings, several infections that were once treatable with oral antibiotics now necessitate intravenous antibiotic therapy.
The dosage and selection of IV antibiotics or antifungals are customized for individual patients, aiming to treat the infection effectively while enabling them to undergo treatment in the comfort of their home, rather than requiring hospitalization.
The beneficial impacts of intravenous immunoglobulin (IVIG) in preventing primary immunodeficiency syndromes have been firmly established. Properly applying IVIG in the treatment of primary immunodeficiency (PI) helps maintain organ function, enhances quality of life, averts infection-related fatalities, and extends the lifespan of patients. The ultimate objective of IVIG therapy is to minimize infections in patients as much as possible.